Provided by Tiger Trade Technology Pte. Ltd.

TRANSCENTA-B

1.080
-0.040-3.57%
Volume:304.00K
Turnover:332.44K
Market Cap:489.24M
PE:-2.20
High:1.125
Open:1.025
Low:1.025
Close:1.120
52wk High:5.800
52wk Low:0.980
Shares:453.00M
HK Float Shares:453.00M
Volume Ratio:1.13
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.490
ROE:-29.75%
ROA:-11.81%
PB:0.68
PE(LYR):-2.20
PS:56.43

Loading ...

Transcenta-B Issues 451,500 Share Awards and 22,500 Share Options

Stock News
·
Jun 30

Transcenta Grants 451,500 Employee Share Awards Under Incentive Scheme

Reuters
·
Jun 30

Transcenta Announces Updated Board Composition and Committee Structure

Bulletin Express
·
Jun 30

Transcenta Files List of Directors, Board Committee Roles and Disclosure-responsible Management

Reuters
·
Jun 30

Transcenta Appoints Hansen Xu as Non-executive Director After Two Independent Directors Resign

Reuters
·
Jun 30

Transcenta-B Shares Surge Nearly 4% on Milestone Payment and CDMO Progress

Stock News
·
Jun 26

TRANSCENTA-B Sets 30 June 2026 AGM; Board Requests Approval of 2025 Results, Director Line-Up and Dual Share Mandates

Bulletin Express
·
Jun 05

Transcenta Holding Sets 30 June 2026 AGM; Board Refresh and 10% Buy-back Mandate on Agenda

Bulletin Express
·
Jun 05

Transcenta-B Proposes Appointment of Xu Hansen as Non-Executive Director

Stock News
·
Jun 04

Transcenta Announces Board Refresh: Two New Directors Proposed, Two INEDs to Step Down

Bulletin Express
·
Jun 04

Transcenta names Hansen Xu non-executive director, Jun Bao independent director

Reuters
·
Jun 04

Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7%

MT Newswires Live
·
May 27

Transcenta Receives RMB 7.00 Million HiCB Milestone, Bolsters CDMO Pipeline with New GMP Contracts

Bulletin Express
·
May 26

TRANSCENTA-B (06628) Announces Milestone Payment for HiCB Out-Licensing and Steady Growth in CDMO Operations

Stock News
·
May 26

Transcenta Holding - Receipt of a Milestone Payment of RMB 7 Mln From Its Hicb Platform Out-Licensing

THOMSON REUTERS
·
May 26

Transcenta Holding Ltd - Negotiating Contracts for Ind Development and Sirna Gmp DP Production

THOMSON REUTERS
·
May 26

Transcenta Says Ozekibart Found to Benefit Patients With Colorectal Cancer

MT Newswires Live
·
May 21

Partner Inhibrx Reports Positive CRC Data for Ozekibart and Submits US BLA for Chondrosarcoma Treatment

Stock News
·
May 21

Transcenta Updates: Partner Inhibrx Posts 20% ORR for Ozekibart in Late-Line Colorectal Cancer, Files U.S. BLA for Chondrosarcoma

Bulletin Express
·
May 21

Transcenta partner Inhibrx reports 20% ORR in ozekibart colorectal cancer trial

Reuters
·
May 21